Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Sort By: Relevancy | Date | Type
Displaying items 13-24 of 139
» View wsbtradio.com items only
    May 9, 2013 |Story| Reuters
  1. Merck, Glaxo reducen precio de vacuna contra cáncer cervical para países pobres

    Reuters
    LONDRES (Reuters) - Las farmacéuticas Merck y GlaxoSmithKline redujeron el precio de las vacunas contra el cáncer de cuello de útero en un acuerdo que les permitirá venderlas a los países más pobres por menos de 5 dólares la dosis. El nuevo precio...

    Tags: Merck & Company Incorporated, Viral Diseases and Infections, HPV Vaccine

  2. May 13, 2013 |Story| AP Broadcast
  3. Elan enters $1 billion royalty deal with Theravance over potential respiratory drug sales

    Irish drugmaker Elan Corp. PLC plans to pay $1 billion for the right to future royalties from four respiratory treatments being developed by Theravance Inc. and GlaxoSmithKline. The deal announced Monday will give Elan 21 percent of the future...

    Tags: Elan Corporation Plc, Health Organizations, Moody's Corporation, Food and Drug Administration, Theravance Incorporated

  4. May 13, 2013 |Story| Reuters
  5. Wall St termina plano tras recientes máximos

    Reuters
    Por Caroline Valetkevitch NUEVA YORK (Reuters) - Las acciones cerraron planas el lunes en la bolsa de Nueva York, tomándose un respiro tras trepar a máximos históricos la semana pasada, pero la fortaleza del sector cuidado de la salud ayudó a que los...

    Tags: Elan Corporation Plc, Stock Market, S&P 500, Financial Markets, Nasdaq Composite

  6. May 13, 2013 |Story| Reuters
  7. Elan alcanza acuerdo por regalías de 1.000 mln dlrs con Theravance

    Reuters
    Por Padraic Halpin DUBLIN (Reuters) - Elan intensificó el lunes su intento por mantener su independencia al alcanzar un acuerdo de 1.000 millones de dólares para comprar el 21 por ciento de las regalías que la firma estadounidense Theravance recibe de...

    Tags: Elan Corporation Plc, Biogen Idec Incorporated, Theravance Incorporated

  8. May 13, 2013 |Story| Reuters
  9. US STOCKS-Futures dip after record high; retail sales on tap

    Reuters
    * Elan, Theravance reach royalties deal * Retail sales for April on tap * Futures off: Dow 40 pts, S&P 5.4 pts, Nasdaq 11.75 pts By Chuck Mikolajczak NEW YORK, May 13 (Reuters) - U.S. stock index futures dipped on Monday, indicating the S&P 500 may...

    Tags: Elan Corporation Plc, Stock Market, Sprint Nextel Corporation, Kentucky Fried Chicken, S&P 500

  10. May 13, 2013 |Story| Reuters
  11. Elan's $1 billion drug royalty deal aids bid defense

    Reuters
    DUBLIN (Reuters) - Irish drugmaker Elan Corporation has agreed a $1 billion royalties deal that could soothe concerns about its potentially risky acquisition strategy and fend off a takeover bid from Royalty Pharma. Elan, battling to keep its...

    Tags: Elan Corporation Plc, Shareholders, Companies and Corporations, Food and Drug Administration, Economy, Business and Finance

  12. May 13, 2013 |Story| Reuters
  13. Late payment costs European companies 350 billion euros

    Reuters
    * European businesses forced to write off 3 pct of receivables * Late payment hitting southern Europe harder than the north * Business confidence down across Europe * European Union legislation not enough to help smaller firms By Clare Hutchison...

    Tags: Companies and Corporations, Business Enterprises, Bankruptcy, Business, Private Business Incorporated

  14. May 13, 2013 |Story| Reuters
  15. Elan-Theravance deal a big boost for Baupost, Fidelity

    Reuters
    By Tim McLaughlin BOSTON, May 13 (Reuters) - Fidelity Investments and hedge fund Baupost Group LLC got a lift on Monday from their investment in Theravance Inc after the U.S.-based biopharmaceutical company agreed to a $1 billion royalty deal with...

    Tags: Elan Corporation Plc, Theravance Incorporated, Thomson Corporation, Warren Buffett

  16. May 12, 2013 |Story| Reuters
  17. UPDATE 1-Elan strikes $1 bln royalty deal with Theravance

    Reuters
    * Elan to acquire newly approved Breo as part of $1 bln deal * Irish drugmaker to announce further deals in due course * Looks to outmanoeuvre Royalty with second shareholder dividend By Padraic Halpin DUBLIN, May 13 (Reuters) - Elan stepped up its...

    Tags: Elan Corporation Plc, COPD, Biogen Idec Incorporated, Multiple Sclerosis, Food and Drug Administration

  18. May 9, 2013 |Story| Reuters
  19. PRESS DIGEST-New York Times business news - May 10

    Reuters
    May 10 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. * The Bank of Japan's efforts to reinvigorate the nation's economy are showing...

    Tags: Kennedy Airport, Human papillomavirus, The New York Times, Merck & Company Incorporated, Delta Air Lines

  20. May 2, 2013 |Story| Reuters
  21. JP Morgan, Greenhill advising GSK on sale of soft drinks brands

    Reuters
    LONDON, May 2 (Reuters) - JP Morgan and Greenhill have been appointed to advise GlaxoSmithKline on the sale of its soft drinks brands Lucozade and Ribena, which analysts believe will fetch more than 1 billion pounds ($1.6 billion). A spokesman for...

    Tags: Bain Capital, LLC, Japan, United Kingdom, Deutsche Bank AG, Lion Capital Holdings

  22. Apr 29, 2013 |Story| Reuters
  23. CANADA STOCKS-TSX may open higher after Italy forms new gov't

    Reuters
    April 29 (Reuters) - Canada's main stock index looked set to open higher, with investors encouraged by the formation of a coalition government in Italy that ended two months of political uncertainty in the troubled region. TOP STORIES * New Italian...

    Tags: European Central Bank, Capstone Mining Corporation, Kinross Gold Corporation, Gold and Precious Material, Economy, Business and Finance

< Previous1  2  3 4 5 6 7 8 9 10 11-12Next >
Original site for GlaxoSmithKline PLC topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
GlaxoSmithKline PLC Photos
Dr. Jeffrey Bloss has joined Astellas US LLC as vice pr...
(November 28, 2012)
Dr. Jeffrey Bloss, vice president of scientific and medical affairs, Astellas US LLC
Third grader Kira Lingle of Quakertown rolls up a strea...
(July 10, 2012)
Science in the Summer program
A bottle of Xenical, a weight-loss aid made by GlaxoSmi...
(May 9, 2012)
GlaxoSmithKline launches hostile tender offer for Human Genome Sciences